John Burd, Ph.D.
Dr. Burd is a co-founder and General Partner of Sabur Technology.
Previously Dr. Burd was Founder & CEO of Oculir, developing a remarkable new non-invasive glucose testing technology. Prior to Oculir, Dr. Burd was a General Partner of Windamere Venture Partners and Chairman & CEO of MiraMedica, a company developing computer-aided detection technology for enhanced cancer diagnosis. MiraMedica was sold to Kodak in August 2003. Dr. Burd was previously President & CEO of DexCom, where he directed the company’s work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes. In April 2005, DexCom completed a successful IPO, valuing the company at up to $600 million.
Before founding DexCom, Dr. Burd was the Founder, President, CEO and Chairman of LXN Corporation, which developed and marketed the Duet® Diabetes Control System to healthcare professionals and the In Charge™ Diabetes Control System to the diabetes self-testing market. LXN was sold to Johnson and Johnson in 2000.
Previously, Dr. Burd held executive positions at QUIDEL Corporation, where he directed the development of enzyme immunoassay products for the clinical lab, physician’s office and OTC markets. Prior to joining QUIDEL, Dr. Burd was Executive Vice President and COO for MAST Immunosystems, Inc. where he was responsible for the company’s operations, including research and development, marketing, sales and finance. MAST Immunosystems was purchased by Hitachi Chemical in 1997. Previously, Dr. Burd was involved in other medical product research and development at Miles Laboratories, Inc. (now Bayer Corporation).
Dr. Burd has authored and co-authored numerous articles and his work in the medical and biotechnology field has led to the filing and ownership of twenty-three patents and the development of many innovative medical products. He is also the 2008 Recipient of the Edwin F. Ullman Award. He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin.